查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1933332

全球正子斷層掃描 (PET) 市場：市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的分析以及預測 (2026-2034)

Positron Emission Tomography Scan Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 200 Pages | 商品交期: 請詢問到貨日

價格

正子斷層掃描 (PET) 市場成長驅動因素

由於慢性病發病率上升、對早期精準診斷的需求不斷增長以及成像技術的持續進步，全球正電子發射斷層掃描 (PET) 市場正經歷穩步增長。 正子斷層掃描（PET）是一種核醫學影像技術，能夠可視化體內代謝和生理活動，在腫瘤學、心臟病學和神經病學領域應用廣泛。

2025年全球PET掃描市場規模為187.1億美元。預計該市場將從2026年的194.6億美元成長到2034年的296.7億美元，預測期內（2026-2034年）複合年增長率（CAGR）為5.41%。北美地區憑藉先進的醫療基礎設施、完善的報銷體係以及混合成像系統的廣泛應用，在2025年佔全球市場主導地位，市場佔有率高達52.38%。

新冠疫情的影響

由於封鎖措施以及擇期和非緊急影像檢查的延遲，新冠疫情對PET掃描市場造成了負面影響。包括PET掃描在內的核子醫學服務在2020年經歷了檢查數量的下降。然而，自2021年以來，診斷服務的恢復和患者預後的改善推動了市場的復甦。 PET影像在腫瘤學和神經病學領域日益增長的重要性將使市場重獲動力，並在預測期內保持穩定成長。

市場趨勢

混合影像系統日益普及

影響PET掃描市場的關鍵趨勢之一是混合影像系統（例如PET/CT和PET/MRI）的日益普及。這些系統結合了功能性影像和解剖成像，以提高診斷準確性、治療計劃制定和疾病監測。 歐洲核子醫學協會 (EANM) 於 2023 年發布的指南進一步支持將 PET/MRI 整合到常規臨床實踐中。

放射性示蹤劑研發與人工智慧整合的進展

放射性追蹤劑研發的持續進展正在改善癌症、神經系統疾病和心血管疾病的檢測和監測。此外，人工智慧 (AI) 和機器學習的整合正在增強影像重建、縮短掃描時間並提高工作流程效率，從而提高醫療機構對 PET 掃描的採用率。

市場成長驅動因素

慢性病發生率上升

癌症、神經系統疾病和心血管疾病發生率的上升是推動 PET 檢測需求的主要驅動因素。 PET 影像在早期檢測、分期和治療追蹤中發揮關鍵作用。根據世界衛生組織估計，帕金森氏症和阿茲海默症等神經系統疾病在全球範圍內持續增加，推動了對先進診斷影像檢測的需求。

對早期精準診斷的需求日益增長

政府措施、不斷增長的醫療保健支出以及對診斷基礎設施的投資正在推動對早期精準診斷工具的需求。 PET掃描具有高靈敏度和特異性，使其成為現代診斷流程的重要組成部分。

限制因子

儘管成長前景良好，但市場仍面臨諸多挑戰，例如設備和檢測成本高昂、放射性藥物供應有限以及新興國家保險覆蓋範圍有限。此外，能夠操作先進影像診斷系統的熟練專業人員短缺仍然是一個主要限制因素，尤其是在發展中地區。

細分市場分析

依適應症劃分

腫瘤學領域預計將在2026年佔66.93%的市場佔有率，這主要得益於全球癌症負擔的加重以及PET掃描在診斷和治療隨訪中日益廣泛的應用。 由於神經系統疾病和心血管疾病的盛行率不斷上升，神經病學和心臟病學領域也佔了相當大的佔有率。

依資金來源劃分

到2026年，公共醫療保險領域佔了84.26%的顯著佔有率，這主要得益於政府對醫療保健的投入以及已開發國家擴大PET成像程序的報銷範圍。

依服務提供者劃分

到2026年，醫院以65.34%的市佔率領先。這得歸功於先進的基礎設施、龐大的患者數量以及混合成像系統的普及。 由於獨立影像設施的增加，診斷中心預計將保持穩定成長。

區域概覽

  • 北美：預計到 2026 年，市場規模將達到 102 億美元，其中美國市場預計到 2026 年將達到 101.1 億美元。
  • 歐洲：慢性病盛行率的上升和 PET 掃描儀安裝量的增加推動了市場成長。
  • 亞太地區：由於醫療保健投資和人口老化，該地區預計將實現最高的複合年增長率。
  • 拉丁美洲、中東和非洲：由於保險覆蓋範圍有限和基礎設施不發達，預計成長速度將放緩。

主要公司

主要公司包括 RadNet, Inc.、Sonic Healthcare Limited、Akumin Inc.、Alliance Medical Limited、Apex Radiology、InHealth Group 和 Novant Health。 策略聯盟、人工智慧整合以及影像診斷網路擴展將繼續是關鍵的競爭策略。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：關鍵考慮因素

  • 主要國家/地區 PET 掃描量（2025 年）
  • 主要國家的監管狀況
  • 主要產業發展動態（併購、合作、新產品發表等）
  • 新冠疫情的影響市場

第五章 全球正子斷層掃描 (PET) 市場分析：洞察與預測 (2021-2034)

  • 市場分析、洞察與預測：依適應症劃分
    • 腫瘤科
    • 心臟科
    • 神經科
    • 其他
  • 市場分析、洞察與預測：依資金來源劃分
    • 公共醫療保險
    • 私人醫療保險/自費
  • 市場分析、洞察與預測：依服務提供者劃分
    • 醫院
    • 診斷中心
    • 其他
  • 市場分析、洞察與預測：依地區劃分
    • 北美美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章 北美正子斷層掃描 (PET) 市場分析：洞察與預測 (2021-2034)

  • 依國家劃分
    • 美國
    • 加拿大

第七章：歐洲正子斷層掃描 (PET) 市場分析：洞察與預測 (2021-2034)

  • 依國家劃分
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪的納維亞
    • 歐洲其他地區

章節第八章 亞太地區正子斷層掃描 (PET) 市場分析：洞察與預測 (2021-2034)

  • 依國家劃分
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 東南亞
    • 亞太其他地區

第九章 拉丁美洲正子斷層掃描 (PET) 市場分析：洞察與預測 (2021-2034)

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區

第十章 中東與非洲正子斷層掃描 (PET) 市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 海灣合作委員會 (GCC) 國家
    • 南非
    • 中東和非洲其他地區

第十一章 競爭分析

  • 全球市佔率分析（2025）
  • 公司簡介
  • RadNet, Inc.
  • Sonic Healthcare Limited
  • Akumin Inc.
  • Apex Radiology
  • Alliance Medical Limited
  • Novant Health
  • InHealth Group
  • Dignity Health
  • Concord Medical
Product Code: FBI111805

Growth Factors of positron emission tomography (PET) scan Market

The global positron emission tomography (PET) scan market is witnessing steady growth due to the increasing burden of chronic diseases, rising demand for early and accurate diagnostics, and continuous advancements in imaging technologies. Positron emission tomography is a nuclear imaging technique that enables visualization of metabolic and physiological activities within the body, making it highly valuable for oncology, cardiology, and neurology applications.

In 2025, the global PET scan market size was valued at USD 18.71 billion. The market is projected to grow from USD 19.46 billion in 2026 to USD 29.67 billion by 2034, registering a CAGR of 5.41% during the forecast period (2026-2034). North America dominated the global market with a 52.38% market share in 2025, supported by advanced healthcare infrastructure, strong reimbursement frameworks, and widespread adoption of hybrid imaging systems.

COVID-19 Impact

The COVID-19 pandemic had a negative impact on the PET scan market due to lockdowns and the postponement of elective and non-emergency imaging procedures. Nuclear medicine services, including PET scans, experienced a decline in procedure volumes during 2020. However, since 2021, the resumption of diagnostic services and improved patient outcomes have supported market recovery. The growing importance of PET imaging in oncology and neurology has enabled the market to regain momentum and maintain steady growth during the forecast period.

Market Trends

Increasing Adoption of Hybrid Imaging Systems

One of the key trends shaping the PET scan market is the growing adoption of hybrid imaging systems such as PET/CT and PET/MRI. These systems combine functional and anatomical imaging, enhancing diagnostic accuracy, treatment planning, and disease monitoring. Guidelines published by the European Association of Nuclear Medicine (EANM) in 2023 have further supported the integration of PET/MRI into routine clinical practice.

Advancements in Radiotracer Development and AI Integration

Continuous advancements in radiotracer development are improving the detection and monitoring of cancers, neurological, and cardiovascular disorders. Additionally, the integration of artificial intelligence and machine learning is enhancing image reconstruction, reducing scan time, and improving workflow efficiency, thereby increasing PET scan adoption across healthcare facilities.

Market Growth Drivers

Rising Prevalence of Chronic Diseases

The rising incidence of cancer, neurological disorders, and cardiovascular diseases is a major driver of PET scan demand. PET imaging plays a critical role in early detection, disease staging, and treatment monitoring. According to WHO estimates, neurological disorders such as Parkinson's disease and Alzheimer's disease continue to rise globally, boosting demand for advanced diagnostic imaging.

Growing Demand for Early and Accurate Diagnosis

Government initiatives, increased healthcare spending, and investments in diagnostic infrastructure are driving demand for early and precise diagnostic tools. PET scans provide high sensitivity and specificity, making them an essential component of modern diagnostic pathways.

Restraining Factors

Despite favorable growth prospects, the market faces challenges due to high equipment and procedure costs, limited availability of radiopharmaceuticals, and restricted reimbursement policies in emerging countries. Additionally, the shortage of skilled professionals capable of operating advanced imaging systems remains a key constraint, particularly in developing regions.

Segmentation Analysis

By Indication

The oncology segment dominated the market with a 66.93% share in 2026, driven by the rising global cancer burden and increasing use of PET scans for diagnosis and treatment monitoring. Neurology and cardiology segments also hold significant shares due to increasing prevalence of neurological and cardiovascular disorders.

By Source of Payment

The public reimbursement segment accounted for a major share of 84.26% in 2026, supported by government healthcare funding and expanded reimbursement for PET imaging procedures in developed economies.

By Service Provider

Hospitals led the market with a 65.34% share in 2026, owing to advanced infrastructure, high patient volumes, and availability of hybrid imaging systems. Diagnostic centers are expected to witness steady growth due to increasing standalone imaging facilities.

Regional Insights

  • North America: Generated USD 10.2 billion in 2026, with the U.S. market projected to reach USD 10.11 billion by 2026
  • Europe: Growth supported by rising chronic disease prevalence and expanding PET scanner installations
  • Asia Pacific: Expected to register the highest CAGR due to healthcare investments and aging population
  • Latin America & Middle East & Africa: Moderate growth due to limited reimbursement and infrastructure

Key Industry Players

Major players include RadNet, Inc., Sonic Healthcare Limited, Akumin Inc., Alliance Medical Limited, Apex Radiology, InHealth Group, and Novant Health. Strategic partnerships, AI integration, and expansion of imaging networks remain key competitive strategies.

Conclusion

The global positron emission tomography (PET) scan market is set for steady expansion, growing from USD 18.71 billion in 2025 to USD 29.67 billion by 2034. Rising prevalence of chronic diseases, increasing demand for early and accurate diagnostics, and technological advancements such as hybrid imaging and artificial intelligence are driving market growth. Although high costs, reimbursement limitations, and workforce shortages pose challenges, continued investments in healthcare infrastructure and innovation are expected to support sustained market development over the forecast period.

Segmentation By Indication,Source of Payment, Service Provider, and Region

By Indication * Oncology

  • Cardiology
  • Neurology
  • Others

By Source of Payment * Public

  • Private Health Insurance/Out-of-pocket

By Service Provider * Hospitals

  • Diagnostic Centers
  • Others

By Region * North America (By Indication, By Source of Payment, By Service Provider, By Country)

    • U.S.
    • Canada
  • Europe (By Indication, By Source of Payment, By Service Provider, By Country/Sub-Region)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Indication, By Source of Payment, By Service Provider, By Country/Sub-Region)
    • Japan
    • China
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Indication, By Source of Payment, By Service Provider, By Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Indication, By Source of Payment, By Service Providers, By Country/Sub-Region)
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Number of PET Scans, Key Countries/ Region, 2025
  • 4.2. Regulatory Scenario, By Key Countries/ Region
  • 4.3. Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches, etc.)
  • 4.4. Impact of COVID-19 in the Market

5. Global Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Indication
    • 5.1.1. Oncology
    • 5.1.2. Cardiology
    • 5.1.3. Neurology
    • 5.1.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By Source of Payment
    • 5.2.1. Public
    • 5.2.2. Private Health Insurance/Out-of-pocket
  • 5.3. Market Analysis, Insights and Forecast - By Service Provider
    • 5.3.1. Hospitals
    • 5.3.2. Diagnostic Centers
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Indication
    • 6.1.1. Oncology
    • 6.1.2. Cardiology
    • 6.1.3. Neurology
    • 6.1.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By Source of Payment
    • 6.2.1. Public
    • 6.2.2. Private Health Insurance/Out-of-pocket
  • 6.3. Market Analysis, Insights and Forecast - By Service Provider
    • 6.3.1. Hospitals
    • 6.3.2. Diagnostic Centers
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Indication
    • 7.1.1. Oncology
    • 7.1.2. Cardiology
    • 7.1.3. Neurology
    • 7.1.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By Source of Payment
    • 7.2.1. Public
    • 7.2.2. Private Health Insurance/Out-of-pocket
  • 7.3. Market Analysis, Insights and Forecast - By Service Provider
    • 7.3.1. Hospitals
    • 7.3.2. Diagnostic Centers
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.4.1. Germany
    • 7.4.2. U.K.
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia Pacific Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Indication
    • 8.1.1. Oncology
    • 8.1.2. Cardiology
    • 8.1.3. Neurology
    • 8.1.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By Source of Payment
    • 8.2.1. Public
    • 8.2.2. Private Health Insurance/Out-of-pocket
  • 8.3. Market Analysis, Insights and Forecast - By Service Provider
    • 8.3.1. Hospitals
    • 8.3.2. Diagnostic Centers
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Indication
    • 9.1.1. Oncology
    • 9.1.2. Cardiology
    • 9.1.3. Neurology
    • 9.1.4. Others
  • 9.2. Market Analysis, Insights and Forecast - By Source of Payment
    • 9.2.1. Public
    • 9.2.2. Private Health Insurance/Out-of-pocket
  • 9.3. Market Analysis, Insights and Forecast - By Service Provider
    • 9.3.1. Hospitals
    • 9.3.2. Diagnostic Centers
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Indication
    • 10.1.1. Oncology
    • 10.1.2. Cardiology
    • 10.1.3. Neurology
    • 10.1.4. Others
  • 10.2. Market Analysis, Insights and Forecast - By Source of Payment
    • 10.2.1. Public
    • 10.2.2. Private Health Insurance/Out-of-pocket
  • 10.3. Market Analysis, Insights and Forecast - By Service Provider
    • 10.3.1. Hospitals
    • 10.3.2. Diagnostic Centers
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles (Overview, Services, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
    • 11.2.1. RadNet, Inc.
    • 11.2.2. Sonic Healthcare Limited
    • 11.2.3. Akumin Inc.
    • 11.2.4. Apex Radiology
    • 11.2.5. Alliance Medical Limited
    • 11.2.6. Novant Health
    • 11.2.7. InHealth Group
    • 11.2.8. Dignity Health
    • 11.2.9. Concord Medical

List of Tables

  • Table 1: Global Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Indication, 2021-2034
  • Table 2: Global Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Source of Payment, 2021-2034
  • Table 3: Global Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Service Provider, 2021-2034
  • Table 4: Global Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Region, 2021-2034
  • Table 5: North America Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Indication, 2021-2034
  • Table 6: North America Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Source of Payment, 2021-2034
  • Table 7: North America Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Service Provider, 2021-2034
  • Table 8: North America Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 9: Europe Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Indication, 2021-2034
  • Table 10: Europe Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Source of Payment, 2021-2034
  • Table 11: Europe Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Service Provider, 2021-2034
  • Table 12: Europe Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 13: Asia Pacific Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Indication, 2021-2034
  • Table 14: Asia Pacific Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Source of Payment, 2021-2034
  • Table 15: Asia Pacific Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Service Provider, 2021-2034
  • Table 16: Asia Pacific Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 17: Latin America Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Indication, 2021-2034
  • Table 18: Latin America Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Source of Payment, 2021-2034
  • Table 19: Latin America Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Service Provider, 2021-2034
  • Table 20: Latin America Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 21: Middle East & Africa Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Indication, 2021-2034
  • Table 22: Middle East & Africa Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Source of Payment, 2021-2034
  • Table 23: Middle East & Africa Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Service Provider, 2021-2034
  • Table 24: Middle East & Africa Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034

List of Figures

  • Figure 1: Global Positron Emission Tomography Scan Market Revenue Breakdown (USD billion, %), By Region, 2025 & 2034
  • Figure 2: Global Positron Emission Tomography Scan Market Value Share (%), By Indication, 2025 & 2034
  • Figure 3: Global Positron Emission Tomography Scan Market Value Share (%), By Source of Payment, 2025 & 2034
  • Figure 4: Global Positron Emission Tomography Scan Market Value Share (%), By Service Provider, 2025 & 2034
  • Figure 5: Global Positron Emission Tomography Scan Market Value Share (%), By Region, 2025 & 2034
  • Figure 6: North America Positron Emission Tomography Scan Market Value (USD billion), By Indication, 2025 & 2034
  • Figure 7: North America Positron Emission Tomography Scan Market Value Share (%), By Indication, 2025
  • Figure 8: North America Positron Emission Tomography Scan Market Value (USD billion), By Source of Payment, 2025 & 2034
  • Figure 9: North America Positron Emission Tomography Scan Market Value Share (%), By Source of Payment, 2025
  • Figure 10: North America Positron Emission Tomography Scan Market Value (USD billion), By Service Provider, 2025 & 2034
  • Figure 11: North America Positron Emission Tomography Scan Market Value Share (%), By Service Provider, 2025
  • Figure 12: North America Positron Emission Tomography Scan Market Value (USD billion), By Country, 2025 & 2034
  • Figure 13: North America Positron Emission Tomography Scan Market Value Share (%), By Country, 2025
  • Figure 14: Europe Positron Emission Tomography Scan Market Value (USD billion), By Indication, 2025 & 2034
  • Figure 15: Europe Positron Emission Tomography Scan Market Value Share (%), By Indication, 2025
  • Figure 16: Europe Positron Emission Tomography Scan Market Value (USD billion), By Source of Payment, 2025 & 2034
  • Figure 17: Europe Positron Emission Tomography Scan Market Value Share (%), By Source of Payment, 2025
  • Figure 18: Europe Positron Emission Tomography Scan Market Value (USD billion), By Service Provider, 2025 & 2034
  • Figure 19: Europe Positron Emission Tomography Scan Market Value Share (%), By Service Provider, 2025
  • Figure 20: Europe Positron Emission Tomography Scan Market Value (USD billion), By Country/Sub-Region, 2025 & 2034
  • Figure 21: Europe Positron Emission Tomography Scan Market Value Share (%), By Country/Sub-Region, 2025
  • Figure 22: Asia Pacific Positron Emission Tomography Scan Market Value (USD billion), By Indication, 2025 & 2034
  • Figure 23: Asia Pacific Positron Emission Tomography Scan Market Value Share (%), By Indication, 2025
  • Figure 24: Asia Pacific Positron Emission Tomography Scan Market Value (USD billion), By Source of Payment, 2025 & 2034
  • Figure 25: Asia Pacific Positron Emission Tomography Scan Market Value Share (%), By Source of Payment, 2025
  • Figure 26: Asia Pacific Positron Emission Tomography Scan Market Value (USD billion), By Service Provider, 2025 & 2034
  • Figure 27: Asia Pacific Positron Emission Tomography Scan Market Value Share (%), By Service Provider, 2025
  • Figure 28: Asia Pacific Positron Emission Tomography Scan Market Value (USD billion), By Country/Sub-Region, 2025 & 2034
  • Figure 29: Asia Pacific Positron Emission Tomography Scan Market Value Share (%), By Country/Sub-Region, 2025
  • Figure 30: Latin America Positron Emission Tomography Scan Market Value (USD billion), By Indication, 2025 & 2034
  • Figure 31: Latin America Positron Emission Tomography Scan Market Value Share (%), By Indication, 2025
  • Figure 32: Latin America Positron Emission Tomography Scan Market Value (USD billion), By Source of Payment, 2025 & 2034
  • Figure 33: Latin America Positron Emission Tomography Scan Market Value Share (%), By Source of Payment, 2025
  • Figure 34: Latin America Positron Emission Tomography Scan Market Value (USD billion), By Service Provider, 2025 & 2034
  • Figure 35: Latin America Positron Emission Tomography Scan Market Value Share (%), By Service Provider, 2025
  • Figure 36: Latin America Positron Emission Tomography Scan Market Value (USD billion), By Country/Sub-Region, 2025 & 2034
  • Figure 37: Latin America Positron Emission Tomography Scan Market Value Share (%), By Country/Sub-Region, 2025
  • Figure 38: Middle East & Africa Positron Emission Tomography Scan Market Value (USD billion), By Indication, 2025 & 2034
  • Figure 39: Middle East & Africa Positron Emission Tomography Scan Market Value Share (%), By Indication, 2025
  • Figure 40: Middle East & Africa Positron Emission Tomography Scan Market Value (USD billion), By Source of Payment, 2025 & 2034
  • Figure 41: Middle East & Africa Positron Emission Tomography Scan Market Value Share (%), By Source of Payment, 2025
  • Figure 42: Middle East & Africa Positron Emission Tomography Scan Market Value (USD billion), By Service Provider, 2025 & 2034
  • Figure 43: Middle East & Africa Positron Emission Tomography Scan Market Value Share (%), By Service Provider, 2025
  • Figure 44: Middle East & Africa Positron Emission Tomography Scan Market Value (USD billion), By Country/Sub-Region, 2025 & 2034
  • Figure 45: Middle East & Africa Positron Emission Tomography Scan Market Value Share (%), By Country/Sub-Region, 2025
  • Figure 46: Global Positron Emission Tomography Scan Market Share (%), 2025